BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

339 related articles for article (PubMed ID: 32555725)

  • 1. MicroRNA-18a targeting of the STK4/MST1 tumour suppressor is necessary for transformation in HPV positive cervical cancer.
    Morgan EL; Patterson MR; Ryder EL; Lee SY; Wasson CW; Harper KL; Li Y; Griffin S; Blair GE; Whitehouse A; Macdonald A
    PLoS Pathog; 2020 Jun; 16(6):e1008624. PubMed ID: 32555725
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human papillomavirus type 16 E7 oncoprotein-induced upregulation of lysine-specific demethylase 5A promotes cervical cancer progression by regulating the microRNA-424-5p/suppressor of zeste 12 pathway.
    Liu J; Zhao H; Zhang Q; Shi Z; Zhang Y; Zhao L; Ren Y; Ou R; Xu Y
    Exp Cell Res; 2020 Nov; 396(1):112277. PubMed ID: 32918895
    [TBL] [Abstract][Full Text] [Related]  

  • 3. miR-106a Regulates Cell Proliferation and Autophagy by Targeting LKB1 in HPV-16-Associated Cervical Cancer.
    Cui X; Wang X; Zhou X; Jia J; Chen H; Zhao W
    Mol Cancer Res; 2020 Aug; 18(8):1129-1141. PubMed ID: 32345599
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of a proliferation gene cluster associated with HPV E6/E7 expression level and viral DNA load in invasive cervical carcinoma.
    Rosty C; Sheffer M; Tsafrir D; Stransky N; Tsafrir I; Peter M; de Crémoux P; de La Rochefordière A; Salmon R; Dorval T; Thiery JP; Couturier J; Radvanyi F; Domany E; Sastre-Garau X
    Oncogene; 2005 Oct; 24(47):7094-104. PubMed ID: 16007141
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The high-risk HPV oncogene E7 upregulates miR-182 expression through the TGF-β/Smad pathway in cervical cancer.
    Chen J; Deng Y; Ao L; Song Y; Xu Y; Wang CC; Choy KW; Tony Chung KH; Du Q; Sui Y; Yang T; Yang J; Li H; Zou C; Tang T
    Cancer Lett; 2019 Sep; 460():75-85. PubMed ID: 31247272
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ARFHPV E7 oncogene, lncRNA HOTAIR, miR-331-3p and its target, NRP2, form a negative feedback loop to regulate the apoptosis in the tumorigenesis in HPV positive cervical cancer.
    Zhang M; Song Y; Zhai F
    J Cell Biochem; 2018 Jun; 119(6):4397-4407. PubMed ID: 29130509
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human Papillomavirus 16 Oncoprotein Expression Is Controlled by the Cellular Splicing Factor SRSF2 (SC35).
    McFarlane M; MacDonald AI; Stevenson A; Graham SV
    J Virol; 2015 May; 89(10):5276-87. PubMed ID: 25717103
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human papillomavirus type 16 reduces the expression of microRNA-218 in cervical carcinoma cells.
    Martinez I; Gardiner AS; Board KF; Monzon FA; Edwards RP; Khan SA
    Oncogene; 2008 Apr; 27(18):2575-82. PubMed ID: 17998940
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Down-regulation of microRNA-146a is associated with high-risk human papillomavirus infection and epidermal growth factor receptor overexpression in penile squamous cell carcinoma.
    Peta E; Cappellesso R; Masi G; Sinigaglia A; Trevisan M; Grassi A; Di Camillo B; Vassarotto E; Fassina A; Palù G; Barzon L
    Hum Pathol; 2017 Mar; 61():33-40. PubMed ID: 27818285
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HPV16 oncogenes E6 or/and E7 may influence the methylation status of RASSFIA gene promoter region in cervical cancer cell line HT-3.
    Yin F; Wang N; Wang S; Yu F; Sun X; Yu X; Luo B; Zhao C; Wang Y
    Oncol Rep; 2017 Apr; 37(4):2324-2334. PubMed ID: 28260046
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Specific down-modulation of Notch1 signaling in cervical cancer cells is required for sustained HPV-E6/E7 expression and late steps of malignant transformation.
    Talora C; Sgroi DC; Crum CP; Dotto GP
    Genes Dev; 2002 Sep; 16(17):2252-63. PubMed ID: 12208848
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Down-regulation of HPGD by miR-146b-3p promotes cervical cancer cell proliferation, migration and anchorage-independent growth through activation of STAT3 and AKT pathways.
    Yao S; Xu J; Zhao K; Song P; Yan Q; Fan W; Li W; Lu C
    Cell Death Dis; 2018 Oct; 9(11):1055. PubMed ID: 30333561
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Suppression of tumorigenesis by transcription units expressing the antisense E6 and E7 messenger RNA (mRNA) for the transforming proteins of the human papilloma virus and the sense mRNA for the retinoblastoma gene in cervical carcinoma cells.
    Hu G; Liu W; Hanania EG; Fu S; Wang T; Deisseroth AB
    Cancer Gene Ther; 1995 Mar; 2(1):19-32. PubMed ID: 7621252
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Utility of microRNAs and siRNAs in cervical carcinogenesis.
    Díaz-González Sdel M; Deas J; Benítez-Boijseauneau O; Gómez-Cerón C; Bermúdez-Morales VH; Rodríguez-Dorantes M; Pérez-Plasencia C; Peralta-Zaragoza O
    Biomed Res Int; 2015; 2015():374924. PubMed ID: 25874209
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human Papillomavirus 16 Oncoproteins Downregulate the Expression of miR-148a-3p, miR-190a-5p, and miR-199b-5p in Cervical Cancer.
    Han MS; Lee JM; Kim SN; Kim JH; Kim HS
    Biomed Res Int; 2018; 2018():1942867. PubMed ID: 30627542
    [TBL] [Abstract][Full Text] [Related]  

  • 16. miR-34a negatively regulates cell cycle factor Cdt2/DTL in HPV infected cervical cancer cells.
    Singh G; Sharma SK; Singh SK
    BMC Cancer; 2022 Jul; 22(1):777. PubMed ID: 35840896
    [TBL] [Abstract][Full Text] [Related]  

  • 17. miR-2861 acts as a tumor suppressor via targeting EGFR/AKT2/CCND1 pathway in cervical cancer induced by human papillomavirus virus 16 E6.
    Xu J; Wan X; Chen X; Fang Y; Cheng X; Xie X; Lu W
    Sci Rep; 2016 Jul; 6():28968. PubMed ID: 27364926
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Signaling pathways in HPV-associated cancers and therapeutic implications.
    Chen J
    Rev Med Virol; 2015 Mar; 25 Suppl 1():24-53. PubMed ID: 25752815
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Characteristic of S100A7 Induction by the Hippo-YAP Pathway in Cervical and Glossopharyngeal Squamous Cell Carcinoma.
    Kong F; Li Y; Hu E; Wang R; Wang J; Liu J; Zhang J; He D; Xiao X
    PLoS One; 2016; 11(12):e0167080. PubMed ID: 27907036
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Hippo/YAP pathway interacts with EGFR signaling and HPV oncoproteins to regulate cervical cancer progression.
    He C; Mao D; Hua G; Lv X; Chen X; Angeletti PC; Dong J; Remmenga SW; Rodabaugh KJ; Zhou J; Lambert PF; Yang P; Davis JS; Wang C
    EMBO Mol Med; 2015 Nov; 7(11):1426-49. PubMed ID: 26417066
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.